year 17, Issue 6 (November - December 2023)                   Iran J Med Microbiol 2023, 17(6): 629-637 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemi S, Mojtahedi A, Hosseini F. Antibiotic Resistance Pattern and Prevalence of Virulence Factors among ESBLs-producing Escherichia coli Isolates Causing Urinary Tract Infections. Iran J Med Microbiol 2023; 17 (6) :629-637
URL: http://ijmm.ir/article-1-2241-en.html
1- Department of Microbiology, School of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran
2- Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran , mojtahedi.a@gmail.com
Abstract:   (527 Views)

Background and Aim: Urinary tract infections (UTIs) pose a significant global health threat, primarily attributed to bacteria producing extended-spectrum beta-lactamases (ESBLs), with limited treatment options available. The specific genotypes of ESBL-producing strains remain largely unexplored in Guilan (northern Iran). Hence, the objective of this study was to determine the prevalence of ESBL-producing extra-intestinal pathogenic Escherichia coli (ExPEC) among hospitalized patients in this area.
Materials and Methods: In this descriptive cross-sectional study, 269 isolates were examined phenotypically for ESBL production. All ESBLs producing isolates were screened for the presence of virulence and housekeeping genes by polymerase chain reaction (PCR) using specific primers. The antimicrobial susceptibility patterns were determined using the disk diffusion method according to the CLSI recommendation.
Results: Out of the 269 E. coli isolates, 107 cases (39.8%) were identified as producers of ESBLs. Antibiotic susceptibility testing conducted on the ESBL-producing isolates revealed the highest levels of resistance to cefotaxime, ampicillin, amoxicillin-clavulanate, cephalothin, cefixime, and ceftriaxone (100.0%). Nalidixic acid exhibited a resistance rate of 91.6%, followed by ceftazidime at 84.1%. On the other hand, the isolates showed the highest susceptibility to imipenem (94.4%), followed by nitrofurantoin (87.9%) and gentamicin (63.9%).
Conclusion: The frequency of ESBL-producing ExPEC isolated from UTIs is concerning in Guilan. The most suitable antibiotic with the lowest risk of resistance for the patient can be prescribed using the updated susceptibility and resistance patterns of the bacteria.

Full-Text [PDF 622 kb]   (320 Downloads) |   |   Full-Text (HTML)  (18 Views)  
Type of Study: Original Research Article | Subject: Medical Bacteriology
Received: 2023/09/12 | Accepted: 2024/01/20 | ePublished: 2024/01/29

References
1. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128(6):1037-50. [DOI:10.1016/j.cell.2007.03.004] [PMID]
2. Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90-101. [DOI:10.1016/j.sjbs.2014.08.002] [PMID] [PMCID]
3. Ibrahimagić A, Bedenić B, Kamberović F, Uzunović S. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings. J Infect Chemother. 2015;21(5):363-9. [DOI:10.1016/j.jiac.2015.01.003] [PMID]
4. Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10:888205. [DOI:10.3389/fpubh.2022.888205] [PMID] [PMCID]
5. Fatima S, Akbar A, Irfan M, Shafee M, Ali A, Ishaq Z, et al. Virulence Factors and Antimicrobial Resistance of Uropathogenic Escherichia coli EQ101 UPEC Isolated from UTI Patient in Quetta, Balochistan, Pakistan. Biomed Res Int. 2023;2023:7278070. [DOI:10.1155/2023/7278070] [PMID] [PMCID]
6. Yang Q, Zhang H, Wang Y, Xu Z, Zhang G, Chen X, et al. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014. BMC Infect Dis. 2017;17(1):192. [DOI:10.1186/s12879-017-2296-x] [PMID] [PMCID]
7. Zhang H, Kong H, Yu Y, Wu A, Duan Q, Jiang X, et al. Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC Infect Dis. 2018;18:493. [DOI:10.1186/s12879-018-3405-1] [PMID] [PMCID]
8. Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol. 2012;3:9. [DOI:10.3389/fmicb.2012.00009] [PMID] [PMCID]
9. Rushton HG. Urinary tract infections in children: epidemiology, evaluation, and management. Pediatr Clin North Am. 1997;44(5):1133-69. [DOI:10.1016/S0031-3955(05)70551-4] [PMID]
10. Sageerabanoo S, Malini A, Mangaiyarkarasi T, Hemalatha G. Phenotypic detection of extended spectrum β-lactamase and Amp-C β-lactamase producing clinical isolates in a Tertiary Care Hospital: A preliminary study. J Nat Sci Biol Med. 2015;6(2):383-7. [DOI:10.4103/0976-9668.160014] [PMID] [PMCID]
11. Performance Standards for Antimicrobial Susceptibility Testing. M100, 30th ed. January 2020. Available online: [https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf]
12. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother. 2003;47(12):3724-32. [DOI:10.1128/AAC.47.12.3724-3732.2003] [PMID] [PMCID]
13. Rehman N, Azam S, Ali A, Asghar M, Ali M, Waqas M, et al. Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, Pakistan. Saudi J Biol Sci. 2021;28(11):6568-81. [DOI:10.1016/j.sjbs.2021.07.028] [PMID] [PMCID]
14. Mendonça N, Leitao J, Manageiro V, Ferreira E, Canica M. Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother. 2007;51(6):1946-55. [DOI:10.1128/AAC.01412-06] [PMID] [PMCID]
15. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother. 2009;64(2):274-7. [DOI:10.1093/jac/dkp194] [PMID]
16. Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014; 52(5):1358-65. [DOI:10.1128/JCM.03502-13] [PMID] [PMCID]
17. Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, et al. Escherichia coli sequence type 131 (ST131) subclone H 30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis. 2013;57(9):1256-65. [DOI:10.1093/cid/cit503] [PMID] [PMCID]
18. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, et al. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and-negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrob Agents Chemother. 2013;57(12):6385-8. [DOI:10.1128/AAC.01604-13] [PMID] [PMCID]
19. Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of an uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43(12):5860-4. [DOI:10.1128/JCM.43.12.5860-5864.2005] [PMID] [PMCID]
20. Negeri AA, Mamo H, Gurung JM, Firoj Mahmud AK, Fällman M, Seyoum ET, et al. Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum β-lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: the presence of international high-risk clones ST131 and ST410 revealed. Front Microbiol. 2021;12:706846. [DOI:10.3389/fmicb.2021.706846] [PMID] [PMCID]
21. Abdelrahim SS, Fouad M, Abdallah N, Ahmed RF, Zaki S. Comparative study of CTX-M-15 producing Escherichia coli ST131 clone isolated from urinary tract infections and acute diarrhoea. Infect Drug Resist. 2021:4027-38. [DOI:10.2147/IDR.S325669] [PMID] [PMCID]
22. Rasoulinasab M, Shahcheraghi F, Feizabadi MM, Nikmanesh B, Hajihasani A, Aslani MM. Distribution of ciprofloxacin-resistance genes among ST131 and non-ST131 clones of Escherichia coli isolates with ESBL phenotypes isolated from women with urinary tract infection. Iran J Microbiol. 2021;13(3):294. [DOI:10.18502/ijm.v13i3.6389] [PMID] [PMCID]
23. Namaei MH, Yousefi M, Ziaee M, Salehabadi A, Ghannadkafi M, Amini E, et al. First report of prevalence of CTX-M-15-producing Escherichia coli O25b/ST131 from Iran. Microb Drug Resist. 2017;23(7):879-84. [DOI:10.1089/mdr.2016.0272] [PMID] [PMCID]
24. Bulut ME, Hürkal G, Dalgıç N. Investigation of High-Risk ST131 Clone in Extended Spectrum β-Lactamase-Producing Escherichia coli isolates in Children. J Pediatr Infect Dis. 2021;16(04):178-82. [DOI:10.1055/s-0041-1730995]
25. Dziri O, Dziri R, Maraoub A, Chouchani C. Characterization of O25b-ST131 Escherichia coli clone producing CTX-M-15, DHA-4, and CMY-42 in urinary tract infections in a Tunisian Island. Microb Drug Resist. 2020;26(7):741-6. [DOI:10.1089/mdr.2019.0076] [PMID]
26. Demirci-Duarte S, Unalan-Altintop T, Eser OK, Cakar A, Altun B, Sancak B, et al. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant. Diagn Microbiol Infect Dis. 2020; 98(1):115098. [DOI:10.1016/j.diagmicrobio.2020.115098] [PMID]
27. Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran. Eur J Clin Microbiol Infect Dis. 2017; 36:1859-66. [DOI:10.1007/s10096-017-3021-9] [PMID]
28. Salehi S, Nakhaei Moghadam M, Asgharian Rezaei Y, Najimi M, Yousefi E. Antibiotic Resistance Pattern and Prevalence of tetA, tetB, tetR, OXA-10 and OXA-48 Resistance Genes among Escherichia coli Isolates from Toilets in Mashhad Azad University (Iran) in 2020. Iran J Med Microbiol. 2023;17(2):167-175. [DOI:10.30699/ijmm.17.2.167]
29. Kadivarian S, Hosseinabadi S, Abiri R, Kooti S, Alvandi A. Frequency of Extended-Spectrum Beta-Lactamase-producing Genes associated in gram-negative bacteria isolated from infectious patients in Kermanshah (2019-2020). Iran J Med Microbiol. 2023;17(1):39-49. [DOI:10.30699/ijmm.17.1.39]
30. Shahandeh Z, Sadighian F, Kalantrai N. Prevalence Escherichia coli, Klebsiella and Enterobacter Species and AmpC-producing Enterobacteriaceae in Clinical Specimens of Hospitals Affiliated to Babol University of Medical Sciences, Iran using Phenotypic and Molecular Methods. Iran J Med Microbiol. 2022;16(3):212-220. [DOI:10.30699/ijmm.16.3.212]
31. Babaheidarian P, Mehdinejad M, Zare-Mirzaie A, Mokarinejad R, Jafari E. The Association between Genetic Variants in Extended Spectrum Beta-Lactamases and AmpC-producing Gram-Negative Bacilli and Antibiotic Resistance. Iran J Med Microbiol. 2022;16(2):116-126. [DOI:10.30699/ijmm.16.2.116]
32. Barzegar S, Arzanlou M, Teimourpour A, Esmaelizad M, Yousefipour M, MohammadShahi J, et al. Prevalence of the Integrons and ESBL Genes in Multidrug-Resistant Strains of Escherichia coli Isolated from Urinary Tract Infections, Ardabil, Iran. Iran J Med Microbiol. 2022;16(1):56-65. [DOI:10.30699/ijmm.16.1.56]
33. Khashei R, Navabi Z, Mohebi S, Samadi N. Antibiotic Resistance Among Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii Isolates Obtained from Shiraz Nemazi Hospital ICU Wards. Iran J Med Microbiol. 2018;12(4):294-300. [DOI:10.30699/ijmm.12.4.294]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc